Kivexa® and Viramune® are antiretroviral medicinal products for the treatment of Human Immunodeficiency Virus (HIV) infection in adults, adolescents, and children. A number of generic products have been recently launched for the originator products, Kivexa® and Viramune® 400mg prolonged-release tablets. This bulletin summarises the new generic products: abacavir + lamivudine tablets and nevirapine prolonged-release tablets and compares the products to their reference product.
NOTE: The content of this resource has not been updated since the publication date. Some information may be out of date and links to other documents or website may not work.